Extracellular vesicles and miRNA-based therapies in triple-negative breast cancer: advances and clinical perspectives
{{output}}
Triple-negative breast cancer (TNBC) is one of the most aggressive and challenging subtypes for treatment, due to the lack of hormone receptors and the human epidermal growth factor receptor 2 (HER2) protein. The identification of new molecular targets is impo... ...
